Skip to content

Sunshine Biopharma Inc.: 10-Q/A filed 2020-08-31

What Sunshine Biopharma Inc. reported in its quarterly report amendment filed 2020-08-31 (fiscal Q2 2020): 37 published measures, 106 facts as tagged in accession 0001654954-20-009628.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
10-Q/A (quarterly report amendment)
Filed
2020-08-31
Fiscal period
fiscal Q2 2020
Accession
0001654954-20-009628 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Sunshine Biopharma Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-06-30138,517USD
At 2019-12-3198,142USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-06-30665,780USD
At 2019-12-31833,527USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-06-30-527,263USD
At 2020-03-31-816,302USD
At 2019-12-31-735,385USD
At 2019-06-30-816,302USD
At 2019-03-31-211,772USD
At 2018-12-31-55,753USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-06-3085,593USD
At 2019-12-3140,501USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-907,444USD91
2020-01-01 to 2020-06-30-1,001,703USD182
2019-04-01 to 2019-06-30-710,890USD91
2019-01-01 to 2019-06-30-913,432USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-01-01 to 2020-06-30-113,050USD182
2019-01-01 to 2019-06-30-281,423USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2020-04-01 to 2020-06-3015,145USD91
2020-01-01 to 2020-06-3026,247USD182
2019-04-01 to 2019-06-303,033USD91
2019-01-01 to 2019-06-303,239USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-01-01 to 2020-06-30159,007USD182
2019-01-01 to 2019-06-30219,428USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2020-01-01 to 2020-06-300USD182
2019-01-01 to 2019-06-30-12,976USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-06-30-18,436,339USD
At 2019-12-31-17,434,636USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2020-04-01 to 2020-06-30153,069,298shares91
2020-01-01 to 2020-06-30101,111,514shares182
2019-04-01 to 2019-06-304,973,649shares91
2019-01-01 to 2019-06-304,641,040shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-0.01USD/shares91
2020-01-01 to 2020-06-30-0.01USD/shares182
2019-04-01 to 2019-06-30-0.14USD/shares91
2019-01-01 to 2019-06-30-0.2USD/shares181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-06-3026,352USD
At 2019-12-3132,456USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-128,569USD91
2020-01-01 to 2020-06-30-166,268USD182
2019-04-01 to 2019-06-30-66,197USD91
2019-01-01 to 2019-06-30-188,406USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-06-30112,165USD
At 2019-12-3165,686USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2020-04-01 to 2020-06-3024,219USD91
2020-01-01 to 2020-06-3040,575USD182
2019-04-01 to 2019-06-3018,342USD91
2019-01-01 to 2019-06-3064,639USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-06-30602,546USD
At 2019-12-31833,527USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-06-3089,883USD
At 2019-12-3196,882USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2020-06-300USD
At 2019-12-310USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2020-06-300USD
At 2019-12-31430USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2020-06-3016,576USD
At 2019-12-3115,910USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2020-04-01 to 2020-06-309,984USD91
2020-01-01 to 2020-06-3017,203USD182
2019-04-01 to 2019-06-301,573USD91
2019-01-01 to 2019-06-301,667USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2020-04-01 to 2020-06-305,161USD91
2020-01-01 to 2020-06-309,044USD182
2019-04-01 to 2019-06-301,460USD91
2019-01-01 to 2019-06-301,572USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2020-04-01 to 2020-06-300USD91
2020-01-01 to 2020-06-300USD182
2019-04-01 to 2019-06-300USD91
2019-01-01 to 2019-06-300USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-06-30269,821,248shares
At 2019-12-3135,319,990shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2020-06-3017,542,616USD
At 2019-12-3116,616,426USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2020-06-30-3,360USD
At 2019-12-31-2,495USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2020-06-3043,723USD
At 2019-12-3137,109USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-906,968USD91
2020-01-01 to 2020-06-30-1,002,568USD182
2019-04-01 to 2019-06-30-708,391USD91
2019-01-01 to 2019-06-30-911,718USD181

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-906,968USD91
2020-01-01 to 2020-06-30-1,002,568USD182
2019-04-01 to 2019-06-30-708,391USD91
2019-01-01 to 2019-06-30-911,718USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2020-04-01 to 2020-06-30138,553USD91
2020-01-01 to 2020-06-30183,471USD182
2019-04-01 to 2019-06-3067,770USD91
2019-01-01 to 2019-06-30190,073USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2020-04-01 to 2020-06-303,491USD91
2020-01-01 to 2020-06-307,002USD182
2019-04-01 to 2019-06-303,415USD91
2019-01-01 to 2019-06-306,829USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-778,875USD91
2020-01-01 to 2020-06-30-835,435USD182
2019-04-01 to 2019-06-30-64,568USD91
2019-01-01 to 2019-06-30-142,789USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2020-01-01 to 2020-06-300USD182
2019-01-01 to 2019-06-3011,034USD181

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2020-01-01 to 2020-06-300USD182
2019-01-01 to 2019-06-300USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-06-30-430USD182
2019-01-01 to 2019-06-301,023USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-06-30666USD182
2019-01-01 to 2019-06-3018,193USD181

Inspect the source

Entity
Sunshine Biopharma Inc. / CIK 0001402328
Captured
2026-09-20T08:00:47.083Z
SEC response SHA-256
089eb69bd01c2bc993f5073ccdb651eba31ddb7f7ea640d657095dcd4ddd9932

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001402328.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))